InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score54
United States Fiscal year ends December CIK 0000899923 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Rashmi Kumar
8 Jun 2026
Director
Sold on a plan
15,000
$4.46
$66.84K
Paul J Diaz
11 Oct 2024
President and CEO
Sold on a plan
15,000
$22.93
$343.95K
Paul J Diaz
11 Sep 2024
President and CEO
Sold on a plan
15,000
$26.72
$400.80K
Colleen F Reitan
3 Sep 2024
Director
Sold on a plan
46,012
$27.95
$1.29M
Rashmi Kumar
19 Aug 2024
Director
Sold on a plan
7,500
$28.01
$210.08K
Daniel K Spiegelman
4 Jun 2024
Director
Sold on a plan
3,788
$22.05
$83.53K
Daniel K Spiegelman
3 Jun 2024
Director
Sold on a plan
3,788
$22.04
$83.49K
Richard Bryan Riggsbee
1 Dec 2023
Chief Financial Officer
Sold on a plan
30,000
$19.09
$572.84K
Richard Bryan Riggsbee
1 Nov 2023
Chief Financial Officer
Sold on a plan
30,000
$15.69
$470.62K
Show all 135 transactions →

What was left out

Form 4 filings counted 546
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 78
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 15,234,074
Sales filed before the plan box existed 26
History held since 18 Oct 2006